Announcements Trials
Browse Landscape

Phase

Phase NA 23Phase 1/2 7Phase 2 6Phase 1 5Phase 2/3 3

Status

Completed 5Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 7Genitourinary 2Tumor-Agnostic 1Thoracic 1Dermatologic 1

Conditions

Pancreatic Neoplasms 3Liver Neoplasms 1Liver Metastasis Colon Cancer 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 153Oxaliplatin 124Fluorouracil 108Capecitabine 105pembrolizumab 92Bevacizumab 79Leucovorin 76Irinotecan 72Nivolumab 70130-nm albumin-bound paclitaxel 68Paclitaxel 62Cisplatin 62Cetuximab 60Cyclophosphamide 47Albumin-Bound Paclitaxel 45Radiotherapy 39Docetaxel 36durvalumab 33Sorafenib 32Taxes 29Carboplatin 27fludarabine 26tislelizumab 25Drug Therapy 25atezolizumab 23Folfox protocol 23regorafenib 20lenvatinib 19Ipilimumab 19sintilimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 1/2 × Electroporation × Gastrointestinal × Clear all
NCT06047015 2024-08-09

Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer

University of Saskatchewan

Phase 1/2 Not yet recruiting
12 enrolled
Gastrointestinal

Liver Metastasis Colon Cancer

NCT01939665 2022-12-20

PANFIRE

Amsterdam UMC, location VUmc

Phase 1/2 Completed
50 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04816045 2021-03-25

Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial

Zealand University Hospital

Phase 1/2 Unknown
24 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03180437 2020-11-02

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
62 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03183219 2020-07-13

Safety and Efficiency of γδ T Cell Against Liver Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Gastrointestinal

Liver Neoplasms

NCT02718859 2019-09-12

Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03008343 2019-09-12

Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡